← Leaderboards
Cornelia M Ulrich
Fred Hutchinson Cancer Research Center
$28,998,049
Attributed
$55,382,985
Total exposure
23
Grants
19
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $10.4M · FY2005–25$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$92,319,854 · 24
By mechanism
P30$42,909,195 · 5
R01$26,268,707 · 10
U01$22,194,686 · 2
R03$528,795 · 4
U54$220,471 · 2
R21$198,000 · 1
Top collaborators
- Christopher I Li21 shared
- Jane C. Figueiredo13 shared
- David Shibata10 shared
- Adetunji T Toriola10 shared
- Erin Siegel8 shared
- Doratha Armenthus Byrd7 shared
- Mary Christine Playdon7 shared
- Scott A Summers7 shared
Most similar at Fred Hutchinson Cancer Research Center
Same institution · by research overlap
- Mario Kratz$940,028
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsResourcesResearch PersonnelGeneticFundingUtahAreaProgramsCancer CenterCohortInstitutesInnovationCancer RiskResponseCancer Center Support GrantPopulation SciencesBaseResource SharingMissionLaboratoriesMemberPopulation DatabaseDesignTranslations
Grant awards (158)
Cancer Center Support Grant$4,411,268
P30 · FY2025 · CA · contact PI
Transdisciplinary Team Science in Colorectal Cancer Prognosis: the ColoCare Study$1,724,414
U01 · FY2025 · CA · contact PI
Ceramides as novel drivers of metabolic dysfunction and colorectal cancer$875,957
U01 · FY2025 · CA
Body composition and adiposity-associated thromboinflammation in colorectal cancer prognosis$664,642
R01 · FY2025 · CA
Adipose tissue-colorectal tumor cross-talk: new targets for breaking the obesity-cancer link$627,133
R01 · FY2025 · CA · contact PI
Developmental Funds$275,703
P30 · FY2025 · CA · contact PI
Transdisciplinary Team Science in Colorectal Cancer Prognosis: the ColoCare Study$95,364
U01 · FY2025 · CA · contact PI
Transdisciplinary Team Science in Colorectal Cancer Prognosis: the ColoCare Study$91,144
U01 · FY2025 · CA · contact PI
Ceramides as novel drivers of metabolic dysfunction and colorectal cancer$68,468
U01 · FY2025 · CA
Ceramides as novel drivers of metabolic dysfunction and colorectal cancer$47,420
U01 · FY2025 · CA
Cancer Center Support Grant$4,199,958
P30 · FY2024 · CA · contact PI
Transdisciplinary Team Science in Colorectal Cancer Prognosis: the ColoCare Study$1,788,840
U01 · FY2024 · CA · contact PI
Ceramides as novel drivers of metabolic dysfunction and colorectal cancer$907,536
U01 · FY2024 · CA
Body composition and adiposity-associated thromboinflammation in colorectal cancer prognosis$723,643
R01 · FY2024 · CA
Adipose tissue-colorectal tumor cross-talk: new targets for breaking the obesity-cancer link$606,154
R01 · FY2024 · CA · contact PI
Leadership, Planning, and Evaluation$585,434
P30 · FY2024 · CA · contact PI
Developmental Funds$395,924
P30 · FY2024 · CA · contact PI
Strengthening Research, Training and Outreach Capacity in Huntsman Cancer Institute's Mountain West Service Area$200,000
P30 · FY2024 · CA · contact PI
Evaluation of the tumor microenvironment in serous uterine cancers$192,489
P30 · FY2024 · CA · contact PI
Cancer Center Support Grant$190,613
P30 · FY2024 · CA · contact PI
Heterogeneity of tumor transcriptomics in underrepresented populations$100,000
P30 · FY2024 · CA · contact PI
American Indian/Alaskan Native Think Tank$99,983
P30 · FY2024 · CA · contact PI
Transdisciplinary Team Science in Colorectal Cancer Prognosis: the ColoCare Study$95,210
U01 · FY2024 · CA · contact PI
Ceramides as novel drivers of metabolic dysfunction and colorectal cancer$47,420
U01 · FY2024 · CA
Cancer Center Support Grant$4,586,542
P30 · FY2023 · CA · contact PI
Transdisciplinary Team Science in Colorectal Cancer Prognosis: the ColoCare Study$1,848,714
U01 · FY2023 · CA · contact PI
Ceramides as novel drivers of metabolic dysfunction and colorectal cancer$950,923
U01 · FY2023 · CA
Adipose tissue-colorectal tumor cross-talk: new targets for breaking the obesity-cancer link$627,486
R01 · FY2023 · CA · contact PI
Leadership, Planning, and Evaluation$623,277
P30 · FY2023 · CA · contact PI
Developmental Funds$425,308
P30 · FY2023 · CA · contact PI
Harmonizing genomic, transcriptomic, and drug response data across pre-clinical models of cancer to support machine learning approaches for personalized cancer therapy selection$307,975
P30 · FY2023 · CA · contact PI
Enhancing Loon: Increasing Robustness and Generalizing Input Formats for a Visualization Tool for Large-Scale Microscopy Data$231,000
P30 · FY2023 · CA · contact PI
Expanding the reach of cancer genetic services to underserved Spanish-speaking Latina women$215,470
P30 · FY2023 · CA · contact PI
Rural community health center partnerships to develop and implement process for HPV self-collection and follow-up among women overdue for cervical cancer screening$214,999
P30 · FY2023 · CA · contact PI
Strengthening Research, Training and Outreach Capacity in Huntsman Cancer Institute's Mountain West Service Area$200,000
P30 · FY2023 · CA · contact PI
Payment Reform Policy and Cancer Disparities in Delivery of Radiotherapy$124,997
P30 · FY2023 · CA · contact PI
Cancer Center Support Grant$4,417,249
P30 · FY2022 · CA · contact PI
Transdisciplinary Team Science in Colorectal Cancer Prognosis: the ColoCare Study$1,670,811
U01 · FY2022 · CA · contact PI
Ceramides as novel drivers of metabolic dysfunction and colorectal cancer$913,866
U01 · FY2022 · CA
Metabolomic Strategies for Discovery and Validation of Biomarkers of Colorectal Cancer Recurrence$868,657
R01 · FY2022 · CA · contact PI
Adipose tissue-colorectal tumor cross-talk: new targets for breaking the obesity-cancer link$621,414
R01 · FY2022 · CA · contact PI
Leadership, Planning, and Evaluation$583,523
P30 · FY2022 · CA · contact PI
Developmental Funds$402,240
P30 · FY2022 · CA · contact PI
Cancer Center Support Grant$249,999
P30 · FY2022 · CA · contact PI
Cancer Center Support Grant: Developing Global Measures of Cancer Stigma$199,860
P30 · FY2022 · CA · contact PI
Cancer Center Support Grant$190,622
P30 · FY2022 · CA · contact PI
Cancer Center Support Grant$154,772
P30 · FY2022 · CA · contact PI
Cancer Center Support Grant$114,840
P30 · FY2022 · CA · contact PI
Cancer Center Support Grant$4,199,958
P30 · FY2021 · CA · contact PI
Transdisciplinary Team Science in Colorectal Cancer Prognosis: the ColoCare Study$1,936,657
U01 · FY2021 · CA · contact PI
Metabolomic Strategies for Discovery and Validation of Biomarkers of Colorectal Cancer Recurrence$1,034,169
R01 · FY2021 · CA · contact PI
Adipose tissue-colorectal tumor cross-talk: new targets for breaking the obesity-cancer link$677,102
R01 · FY2021 · CA · contact PI
Leadership, Planning, and Evaluation$570,742
P30 · FY2021 · CA · contact PI
Developmental Funds$389,459
P30 · FY2021 · CA · contact PI
Cancer Center Support Grant$249,999
P30 · FY2021 · CA · contact PI
Precision-exercise-prescription for Lung Cancer Patients Undergoing Surgery: The PEP Study$207,702
R01 · FY2021 · CA · contact PI
Research Practice Partnership: Supporting Nevada's Cancer Coalitions Priorities$149,999
P30 · FY2021 · CA · contact PI
Cancer Center Support Grant$137,331
P30 · FY2021 · CA · contact PI
Cancer Center Support Grant$115,000
P30 · FY2021 · CA · contact PI
Cancer Center Support Grant$60,000
P30 · FY2021 · CA · contact PI
Cancer Center Support Grant$4,199,958
P30 · FY2020 · CA · contact PI
Transdisciplinary Team Science in Colorectal Cancer Prognosis: the ColoCare Study$1,967,702
U01 · FY2020 · CA · contact PI
Leadership, Planning, and Evaluation$570,744
P30 · FY2020 · CA · contact PI
Metabolomic Strategies for Discovery and Validation of Biomarkers of Colorectal Cancer Recurrence$555,888
R01 · FY2020 · CA · contact PI
Precision-exercise-prescription for Lung Cancer Patients Undergoing Surgery: The PEP Study$511,375
R01 · FY2020 · CA · contact PI
Discovery and verification of novel biomarkers of colorectal cancer recurrence$420,049
R01 · FY2020 · CA
Developmental Funds$389,461
P30 · FY2020 · CA · contact PI
Cancer Center Support Grant$300,000
P30 · FY2020 · CA · contact PI
Cancer Center Support Grant$250,000
P30 · FY2020 · CA · contact PI
Cancer Center Support Grant$207,851
P30 · FY2020 · CA · contact PI
Cancer Center Support Grant$150,001
P30 · FY2020 · CA · contact PI
Cancer Center Support Grant$115,000
P30 · FY2020 · CA · contact PI
Cancer Center Support Grant$60,000
P30 · FY2020 · CA · contact PI
Cancer Center Support Grant$2,235,000
P30 · FY2019 · CA · contact PI
Transdisciplinary Team Science in Colorectal Cancer Prognosis: the ColoCare Study$1,717,150
U01 · FY2019 · CA · contact PI
Discovery and verification of novel biomarkers of colorectal cancer recurrence$608,367
R01 · FY2019 · CA
Precision-exercise-prescription for Lung Cancer Patients Undergoing Surgery: The PEP Study$486,664
R01 · FY2019 · CA · contact PI
DEVELOPMENTAL FUNDS (Core-002)$374,254
P30 · FY2019 · CA · contact PI
Research Informatics (RI)$260,522
P30 · FY2019 · CA · contact PI
Cancer Center Support Grant$199,989
P30 · FY2019 · CA · contact PI
Cancer Center Support Grant$187,500
P30 · FY2019 · CA · contact PI
Cancer Center Support Grant$155,591
P30 · FY2019 · CA · contact PI
Cancer Center Support Grant$115,000
P30 · FY2019 · CA · contact PI
Cancer Center Support Grant$114,375
P30 · FY2019 · CA · contact PI
Cancer Center Support Grant$83,622
P30 · FY2019 · CA · contact PI
Discovery and verification of novel biomarkers of colorectal cancer recurrence$78,749
R01 · FY2019 · CA
Cancer Center Support Grant$59,759
P30 · FY2019 · CA · contact PI
Cancer Center Support Grant$53,392
P30 · FY2019 · CA · contact PI
Cancer Center Support Grant$50,000
P30 · FY2019 · CA · contact PI
Cancer Center Support Grant$48,350
P30 · FY2019 · CA · contact PI
DEVELOPMENTAL FUNDS (Core-002)$14,286
P30 · FY2019 · CA · contact PI
Research Informatics (RI)$14,285
P30 · FY2019 · CA · contact PI
Research Informatics (RI)$11,114
P30 · FY2019 · CA · contact PI
DEVELOPMENTAL FUNDS (Core-002)$11,114
P30 · FY2019 · CA · contact PI
DEVELOPMENTAL FUNDS (Core-002)$8,215
P30 · FY2019 · CA · contact PI
Research Informatics (RI)$8,215
P30 · FY2019 · CA · contact PI
DEVELOPMENTAL FUNDS (Core-002)$8,171
P30 · FY2019 · CA · contact PI
Research Informatics (RI)$8,170
P30 · FY2019 · CA · contact PI
DEVELOPMENTAL FUNDS (Core-002)$5,974
P30 · FY2019 · CA · contact PI
Research Informatics (RI)$5,973
P30 · FY2019 · CA · contact PI
Research Informatics (RI)$4,269
P30 · FY2019 · CA · contact PI
DEVELOPMENTAL FUNDS (Core-002)$4,269
P30 · FY2019 · CA · contact PI
Research Informatics (RI)$3,814
P30 · FY2019 · CA · contact PI
DEVELOPMENTAL FUNDS (Core-002)$3,814
P30 · FY2019 · CA · contact PI
Research Informatics (RI)$3,572
P30 · FY2019 · CA · contact PI
DEVELOPMENTAL FUNDS (Core-002)$3,572
P30 · FY2019 · CA · contact PI
DEVELOPMENTAL FUNDS (Core-002)$3,454
P30 · FY2019 · CA · contact PI
Research Informatics (RI)$3,454
P30 · FY2019 · CA · contact PI
Cancer Center Support Grant$2,284,970
P30 · FY2018 · CA · contact PI
Transdisciplinary Team Science in Colorectal Cancer Prognosis: the ColoCare Study$1,745,632
U01 · FY2018 · CA · contact PI
Discovery and verification of novel biomarkers of colorectal cancer recurrence$1,061,207
R01 · FY2018 · CA
Metabolomic Strategies for Discovery and Validation of Biomarkers of Colorectal Cancer Recurrence$890,636
R01 · FY2018 · CA · contact PI
Precision-exercise-prescription for Lung Cancer Patients Undergoing Surgery: The PEP Study$507,509
R01 · FY2018 · CA · contact PI
Cancer Center Support Grant$228,331
P30 · FY2018 · CA · contact PI
Cancer Center Support Grant$171,608
P30 · FY2018 · CA · contact PI
Cancer Center Support Grant$151,649
P30 · FY2018 · CA · contact PI
Discovery and verification of novel biomarkers of colorectal cancer recurrence$76,166
R01 · FY2018 · CA
Transdisciplinary Team Science in Colorectal Cancer Prognosis: the ColoCare Study$1,839,122
U01 · FY2017 · CA · contact PI
Discovery and verification of novel biomarkers of colorectal cancer recurrence$1,061,342
R01 · FY2017 · CA
Metabolomic Strategies for Discovery and Validation of Biomarkers of Colorectal Cancer Recurrence$507,585
R01 · FY2017 · CA · contact PI
Precision-exercise-prescription for Lung Cancer Patients Undergoing Surgery: The PEP Study$500,886
R01 · FY2017 · CA · contact PI
Discovery and verification of novel biomarkers of colorectal cancer recurrence$48,248
R01 · FY2017 · CA
Transdisciplinary Team Science in Colorectal Cancer Prognosis: the ColoCare Study$1,862,336
U01 · FY2016 · CA · contact PI
Discovery and verification of novel biomarkers of colorectal cancer recurrence$1,042,128
R01 · FY2016 · CA
Discovery and verification of novel biomarkers of colorectal cancer recurrence$98,960
R01 · FY2016 · CA
Discovery and verification of novel biomarkers of colorectal cancer recurrence$1,084,138
R01 · FY2015 · CA
A Prospective Study of Colorectal Cancer: One-Carbon Metabolism and Inflammation$488,576
R01 · FY2012 · CA · contact PI
A Prospective Study of Colorectal Cancer: One-Carbon Metabolism and Inflammation$605,656
R01 · FY2011 · CA · contact PI
A Prospective Study of Colorectal Cancer: One-Carbon Metabolism and Inflammation$608,726
R01 · FY2010 · CA · contact PI
Prostaglandin Synthesis, Genetics and Colorectal Cancer$504,558
R01 · FY2010 · CA · contact PI
NSAID and COX/PG Metabolism and Colorectal Cancer$679,705
R01 · FY2009 · CA · contact PI
A Prospective Study of Colorectal Cancer: One-Carbon Metabolism and Inflammation$631,879
R01 · FY2009 · CA · contact PI
Prostaglandin Synthesis, Genetics and Colorectal Cancer$559,439
R01 · FY2009 · CA · contact PI
NSAID and COX/PG Metabolism and Colorectal Cancer$326,851
R01 · FY2009 · CA · contact PI
Excercise & diet: biomarkers & mechanisms in humans$141,739
U54 · FY2009 · CA · contact PI
NSAIDs, Genetic Variability, and Colorectal Cancer Survival$83,514
R03 · FY2009 · CA · contact PI
Career Development and Training Core$12,174
U54 · FY2009 · CA · contact PI
NSAID and COX/PG Metabolism and Colorectal Cancer$659,518
R01 · FY2008 · CA · contact PI
A Prospective Study of Colorectal Cancer: One-Carbon Metabolism and Inflammation$641,822
R01 · FY2008 · CA · contact PI
Prostaglandin Synthesis, Genetics and Colorectal Cancer$555,937
R01 · FY2008 · CA · contact PI
Effect of exercise and weight loss on adipose tissue biology$198,000
R21 · FY2008 · CA · contact PI
Aspirin pharmacogenetics in the Aspirin/Folate Polyp Prevention Trial$103,275
R03 · FY2008 · CA · contact PI
NSAIDs, Genetic Variability, and Colorectal Cancer Survival$83,514
R03 · FY2008 · CA · contact PI
Excercise & diet: biomarkers & mechanisms in humans$58,133
U54 · FY2008 · CA · contact PI
Career Development and Training Core$8,425
U54 · FY2008 · CA · contact PI
NSAID and COX/PG Metabolism and Colorectal Cancer$652,079
R01 · FY2007 · CA · contact PI
Prostaglandin Synthesis, Genetics and Colorectal Cancer$544,659
R01 · FY2007 · CA · contact PI
Modeling Folate, One-Carbon Metabolism & DNA Methylation$235,449
R01 · FY2007 · CA · contact PI
Exercise effects on oxidative damage among women$88,000
R03 · FY2007 · CA · contact PI
Genetic Study of Prostaglandin Synthesis/EGFR and Risk of Colorectal Neoplasia$83,992
R03 · FY2007 · CA · contact PI
Prostaglandin Synthesis, Genetics and Colorectal Cancer$540,756
R01 · FY2006 · CA · contact PI
Modeling Folate, One-Carbon Metabolism & DNA Methylation$211,585
R01 · FY2006 · CA · contact PI
Genetic Study of Prostaglandin Synthesis/EGFR and Risk of Colorectal Neoplasia$86,500
R03 · FY2006 · CA · contact PI
Modeling Folate, One-Carbon Metabolism &DNA Methylation$224,462
R01 · FY2005 · CA
Modeling Folate, One-Carbon Metabolism &DNA Methylation$242,712
R01 · FY2004 · CA
POLYMORPHISMS IN PG/COX PATHWAY AND COLORECTAL POLYPS$331,216
R01 · FY2003 · CA
POLYMORPHISMS IN PG/COX PATHWAY AND COLORECTAL POLYPS$410,309
R01 · FY2002 · CA
POLYMORPHISMS IN PG/COX PATHWAY AND COLORECTAL POLYPS$414,814
R01 · FY2001 · CA